{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:09:54Z","timestamp":1790636994373,"version":"4.1.0"},"reference-count":110,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.canrad.2015.02.014","type":"journal-article","created":{"date-parts":[[2015,6,25]],"date-time":"2015-06-25T15:20:51Z","timestamp":1435245651000},"page":"337-346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Param\u00e8tres de radior\u00e9sistance des cancers des voies a\u00e9rodigestives sup\u00e9rieures et strat\u00e9gies de radiosensibilisation"],"prefix":"10.1016","volume":"19","author":[{"given":"J.","family":"Biau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Chautard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Miroir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lapeyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2015.02.014_bib0555","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1684\/bdc.2014.1962","article-title":"\u00c9pid\u00e9miologie et anatomie des cancers ORL","volume":"101","author":"P\u00e9ri\u00e9","year":"2014","journal-title":"Bull Cancer"},{"key":"10.1016\/j.canrad.2015.02.014_bib0560","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1749-4486.2007.01544.x","article-title":"Clinical and biological factors affecting response to radiotherapy in patients with head and neck cancer: a review","volume":"32","author":"Silva","year":"2007","journal-title":"Clin Otolaryngol Surg"},{"key":"10.1016\/j.canrad.2015.02.014_bib0565","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.radonc.2013.06.004","article-title":"Human papillomaviruses and cancer","volume":"108","author":"Haedicke","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0570","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1684\/bdc.2014.1924","article-title":"Crit\u00e8res de qualit\u00e9 en radioth\u00e9rapie des cancers de la t\u00eate et du cou sous l\u2019\u00e9gide de l\u2019intergroupe ORL","volume":"101","author":"Tao","year":"2014","journal-title":"Bull Cancer"},{"key":"10.1016\/j.canrad.2015.02.014_bib0575","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.radonc.2011.12.010","article-title":"Intensity-modulated radiotherapy in head and neck cancer: results of the prospective study GORTEC 2004-03","volume":"103","author":"Toledano","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0580","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.canrad.2011.07.239","article-title":"D\u00e9lin\u00e9ation des volumes cibles des cancers des voies a\u00e9rodigestives sup\u00e9rieures en radioth\u00e9rapie conformationnelle avec modulation d\u2019intensit\u00e9","volume":"15","author":"Lapeyre","year":"2011","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2015.02.014_bib0585","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.radonc.2011.05.036","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site","volume":"100","author":"Blanchard","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0590","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev.med.57.121304.131431","article-title":"Advances in radiation oncology","volume":"57","author":"Elshaikh","year":"2006","journal-title":"Ann Rev Med"},{"key":"10.1016\/j.canrad.2015.02.014_bib0595","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.radonc.2011.03.004","article-title":"Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck: a systematic review and meta-analysis","volume":"100","author":"Overgaard","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0600","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.clon.2006.02.009","article-title":"Radical radiotherapy in head and neck squamous cell carcinoma: an analysis of prognostic and therapeutic factors","volume":"18","author":"Dinshaw","year":"2006","journal-title":"Clin Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0605","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1073\/pnas.11.6.303","article-title":"On the mechanism of X-ray scattering","volume":"11","author":"Compton","year":"1925","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.canrad.2015.02.014_bib0610","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10555-007-9056-0","article-title":"Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment","volume":"26","author":"Moeller","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.canrad.2015.02.014_bib0615","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3109\/02841869509094031","article-title":"Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell radiation resistance in tumours. A review","volume":"34","author":"Horsman","year":"1995","journal-title":"Acta Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0620","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0360-3016(97)00101-6","article-title":"Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck","volume":"38","author":"Brizel","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2015.02.014_bib0625","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.radonc.2005.06.038","article-title":"Prognostic value of tumor oxygenation in 397\u00a0head and neck tumors after primary radiation therapy. An international multi-center study","volume":"77","author":"Nordsmark","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0630","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.radonc.2012.09.015","article-title":"FAZA PET\/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: results from the DAHANCA 24\u00a0trial","volume":"105","author":"Mortensen","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0635","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0360-3016(98)00348-4","article-title":"Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27","volume":"42","author":"Lee","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2015.02.014_bib0640","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1200\/JCO.2008.18.2188","article-title":"Pretreatment health behaviors predict survival among patients with head and neck squamous cell carcinoma","volume":"27","author":"Duffy","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0645","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.radonc.2012.01.011","article-title":"Effect of smoking on oxygen delivery and outcome in patients treated with radiotherapy for head and neck squamous cell carcinoma: a prospective study","volume":"103","author":"Hoff","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0650","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/02841868809090333","article-title":"The hazard of accelerated tumor clonogen repopulation during radiotherapy","volume":"27","author":"Withers","year":"1988","journal-title":"Acta Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0655","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1088\/0031-9155\/49\/16\/021","article-title":"Modelling of post-irradiation accelerated repopulation in squamous cell carcinomas","volume":"49","author":"Marcu","year":"2004","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0660","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0360-3016(02)02936-X","article-title":"How fast is repopulation of tumor cells during the treatment gap?","volume":"54","author":"Tarnawski","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2015.02.014_bib0665","doi-asserted-by":"crossref","first-page":"5560","DOI":"10.1200\/JCO.2005.06.411","article-title":"Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial","volume":"23","author":"Bentzen","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0670","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/cncr.10232","article-title":"p53\u00a0and Ki-67\u00a0as markers of radioresistance in head and neck carcinoma","volume":"94","author":"Couture","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2015.02.014_bib0675","first-page":"7350","article-title":"Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma","volume":"62","author":"Ang","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.canrad.2015.02.014_bib0680","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0167-8140(97)01904-X","article-title":"Importance of overall treatment time for the outcome of radiotherapy of advanced head and neck carcinoma: dependency on tumor differentiation","volume":"43","author":"Hansen","year":"1997","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0685","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/0360-3016(85)90223-8","article-title":"Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: analysis of 101\u00a0published survival curves","volume":"11","author":"Fertil","year":"1985","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2015.02.014_bib0690","doi-asserted-by":"crossref","first-page":"8352","DOI":"10.1158\/0008-5472.CAN-06-0533","article-title":"Tumor cell radiosensitivity is a major determinant of tumor response to radiation","volume":"66","author":"Gerweck","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.canrad.2015.02.014_bib0695","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1158\/0008-5472.CAN-06-4498","article-title":"Influence of tumor cell and stroma sensitivity on tumor response to radiation","volume":"67","author":"Ogawa","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.canrad.2015.02.014_bib0700","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0360-3016(99)00373-9","article-title":"Tumor radiosensitivity (SF2) is a prognostic factor for local control in head and neck cancers","volume":"46","author":"Bj\u00f6rk-Eriksson","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2015.02.014_bib0705","first-page":"4801","article-title":"Tpot and head and neck cancer: where are we now?","volume":"18","author":"Wilson","year":"1998","journal-title":"Anticancer Res"},{"key":"10.1016\/j.canrad.2015.02.014_bib0710","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.canrad.2014.06.003","article-title":"Papillomavirus humain et cancer ORL","volume":"18","author":"Barry","year":"2014","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2015.02.014_bib0715","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2015.02.014_bib0720","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.radonc.2010.04.022","article-title":"The role of human papillomavirus in head and neck cancer and the impact on radiotherapy outcome","volume":"95","author":"Lassen","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0725","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nrc2419","article-title":"Exploring the role of cancer stem cells in radioresistance","volume":"8","author":"Baumann","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.canrad.2015.02.014_bib0730","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1634\/stemcells.2006-0136","article-title":"Successful therapy must eradicate cancer stem cells","volume":"24","author":"Dingli","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.canrad.2015.02.014_bib0735","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.semradonc.2008.11.004","article-title":"Cancer stem cells and tumor response to therapy: current problems and future prospects","volume":"19","author":"Milas","year":"2009","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0740","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.semradonc.2008.11.001","article-title":"Cancer stem cells in solid tumors: an overview","volume":"19","author":"O\u2019Brien","year":"2009","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0745","doi-asserted-by":"crossref","first-page":"9339","DOI":"10.1158\/0008-5472.CAN-06-3126","article-title":"Cancer stem cells: perspectives on current status and future directions: AACR Workshop on cancer stem cells","volume":"66","author":"Clarke","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.canrad.2015.02.014_bib0750","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1158\/0008-5472.CAN-05-3153","article-title":"Cancer stem cells: an old idea: a paradigm shift","volume":"66","author":"Wicha","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.canrad.2015.02.014_bib0755","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.radonc.2007.04.020","article-title":"Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation","volume":"83","author":"Yaromina","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0760","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1200\/JCO.2007.15.1829","article-title":"Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis","volume":"26","author":"Eyler","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0765","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/sj.bjc.6605551","article-title":"Hypoxia inducible factors in cancer stem cells","volume":"102","author":"Heddleston","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.canrad.2015.02.014_bib0770","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/ng.3051","article-title":"Multi-tiered genomic analysis of head and neck cancer ties TP53\u00a0mutation to 3p loss","volume":"46","author":"Gross","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.canrad.2015.02.014_bib0775","first-page":"2263","article-title":"p53\u00a0involvement in control of G2\u00a0exit of the cell cycle: role in DNA damage-induced apoptosis","volume":"10","author":"Guillouf","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.canrad.2015.02.014_bib0780","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.oraloncology.2009.12.007","article-title":"High expression of excision repair cross-complementation group 1\u00a0protein predicts poor outcome in patients with nasopharyngeal cancer","volume":"46","author":"Lee","year":"2010","journal-title":"Oral Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0785","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93\u00a0randomised trials and 17,346\u00a0patients","volume":"92","author":"Pignon","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0790","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/ncponc0714","article-title":"The concurrent chemoradiation paradigm: general principles","volume":"4","author":"Seiwert","year":"2007","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0795","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.canrad.2013.06.038","article-title":"Cancers des voies a\u00e9rodigestives sup\u00e9rieures\u00a0: le retour de la chimioth\u00e9rapie n\u00e9oadjuvante\u00a0?","volume":"17","author":"Calais","year":"2013","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2015.02.014_bib0800","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1200\/JCO.2012.47.7802","article-title":"Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group","volume":"31","author":"Blanchard","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0805","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/annonc\/mdt461","article-title":"A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer","volume":"25","author":"Hitt","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0810","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1200\/JCO.2013.54.6309","article-title":"Phase III randomized trial of induction chemotherapy in patients with N2\u00a0or N3\u00a0locally advanced head and neck cancer","volume":"32","author":"Cohen","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0815","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1470-2045(13)70011-1","article-title":"Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3\u00a0trial","volume":"14","author":"Haddad","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0820","doi-asserted-by":"crossref","first-page":"5s","DOI":"10.1200\/jco.2014.32.15_suppl.6004","volume":"32","author":"Ghi","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0825","doi-asserted-by":"crossref","first-page":"6003","DOI":"10.1200\/jco.2013.31.15_suppl.6003","volume":"31","author":"Ghi","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0830","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2015.02.014_bib0835","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(09)70311-0","article-title":"Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3\u00a0randomised trial, and relation between cetuximab-induced rash and survival","volume":"11","author":"Bonner","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0840","doi-asserted-by":"crossref","first-page":"5s","DOI":"10.1200\/jco.2014.32.15_suppl.6001","article-title":"Impact of p16\u00a0status on the results of the phase III cetuximab (cet)\/radiotherapy (RT)","volume":"32","author":"Rosenthal","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0845","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1200\/JCO.2013.53.5633","article-title":"Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522","volume":"32","author":"Ang","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0850","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ccr.2005.06.016","article-title":"Pleiotropic effects of HIF-1\u00a0blockade on tumor radiosensitivity","volume":"8","author":"Moeller","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canrad.2015.02.014_bib0855","doi-asserted-by":"crossref","first-page":"665","DOI":"10.4161\/cbt.8.8.8304","article-title":"Enhancing radiosensitivity: targeting the DNA repair pathways","volume":"8","author":"Jorgensen","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.canrad.2015.02.014_bib0860","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S1470-2045(08)70073-1","article-title":"Activation of the PI3-K\/AKT pathway and implications for radioresistance mechanisms in head and neck cancer","volume":"9","author":"Bussink","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0865","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1053\/j.seminoncol.2008.03.005","article-title":"Targeting angiogenesis in head and neck cancer","volume":"35","author":"Seiwert","year":"2008","journal-title":"Semin Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0870","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0140-6736(06)69121-6","article-title":"Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis","volume":"368","author":"Bourhis","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2015.02.014_bib0875","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1470-2045(11)70346-1","article-title":"Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3\u00a0randomised trial","volume":"13","author":"Bourhis","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0880","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.radonc.2006.03.003","article-title":"[18F]fluoro-deoxy-glucose positron emission tomography ([18F]FDG-PET) voxel intensity-based intensity-modulated radiation therapy (IMRT) for head and neck cancer","volume":"79","author":"Vanderstraeten","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0885","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijrobp.2006.12.070","article-title":"Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer","volume":"68","author":"Madani","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2015.02.014_bib0890","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.radonc.2011.06.020","article-title":"Maximum tolerated dose in a phase I trial on adaptive dose painting by numbers for head and neck cancer","volume":"101","author":"Madani","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0895","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.ijrobp.2010.03.028","article-title":"Adaptive dose painting by numbers for head-and-neck cancer","volume":"80","author":"Duprez","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2015.02.014_bib0900","first-page":"CD005007","article-title":"Hyperbaric oxygenation for tumour sensitisation to radiotherapy","volume":"4","author":"Bennett","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.canrad.2015.02.014_bib0905","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijrobp.2008.07.039","article-title":"An exploratory study into the role of dynamic contrast-enhanced magnetic resonance imaging or perfusion computed tomography for detection of intratumoral hypoxia in head-and-neck cancer","volume":"74","author":"Newbold","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2015.02.014_bib0910","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cpet.2009.05.009","article-title":"Positron emission tomography imaging of hypoxia","volume":"4","author":"Lapi","year":"2009","journal-title":"PET Clin"},{"key":"10.1016\/j.canrad.2015.02.014_bib0915","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/j.ijrobp.2007.05.043","article-title":"Hypoxia in head and neck cancer: studies with hypoxic positron emission tomography imaging and hypoxic cytotoxins","volume":"69","author":"Rischin","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2015.02.014_bib0920","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ijrobp.2007.05.079","article-title":"Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer","volume":"69","author":"Grosu","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2015.02.014_bib0925","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.3109\/0284186X.2014.990109","article-title":"Hypoxia-guided adaptive radiation dose escalation in head and neck carcinoma: a planning study","volume":"54","author":"Servagi-Vernat","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0930","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00066-014-0752-8","article-title":"Hypoxia imaging with [18F]-FMISO-PET for guided dose escalation with intensity-modulated radiotherapy in head-and-neck cancers","volume":"191","author":"Henriques de Figueiredo","year":"2015","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0935","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.ijrobp.2007.09.050","article-title":"The influence of changes in tumor hypoxia on dose-painting treatment plans based on 18F-FMISO positron emission tomography","volume":"70","author":"Lin","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2015.02.014_bib0940","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.radonc.2013.06.012","article-title":"Exploratory geographical analysis of hypoxic subvolumes using 18F-MISO-PET imaging in patients with head and neck cancer in the course of primary chemoradiotherapy","volume":"108","author":"Bittner","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0945","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1007\/s00259-014-2730-x","article-title":"A prospective clinical study of 18F-FAZA PET-CT hypoxia imaging in head and neck squamous cell carcinoma before and during radiation therapy","volume":"41","author":"Servagi-Vernat","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.canrad.2015.02.014_bib0950","first-page":"529","article-title":"Tirapazamine: laboratory data relevant to clinical activity","volume":"13","author":"Brown","year":"1998","journal-title":"Anticancer Drug Des"},{"key":"10.1016\/j.canrad.2015.02.014_bib0955","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1200\/JCO.2009.27.4449","article-title":"Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02, HeadSTART): a phase III trial of the Trans-Tasman Radiation Oncology Group","volume":"28","author":"Rischin","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0960","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1200\/JCO.2009.27.4498","article-title":"Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02","volume":"28","author":"Peters","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0965","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.radonc.2010.09.024","article-title":"The importance of haemoglobin level and effect of transfusion in HNSCC patients treated with radiotherapy: results from the randomized DAHANCA 5\u00a0study","volume":"98","author":"Hoff","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib0970","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.canrad.2005.01.004","article-title":"Impact de l\u2019an\u00e9mie sur les traitements des cancers du col ut\u00e9rin","volume":"9","author":"Marchal","year":"2005","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2015.02.014_bib0975","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/(SICI)1097-0142(19991001)86:7<1362::AID-CNCR36>3.0.CO;2-T","article-title":"Erythropoietin reduces anemia and transfusions: a randomized trial with or without erythropoietin during chemotherapy","volume":"86","author":"Dunphy","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2015.02.014_bib0980","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1623::AID-CNCR28>3.0.CO;2-Z","article-title":"Erythropoietin reduces anemia and transfusions after chemotherapy with paclitaxel and carboplatin","volume":"79","author":"Dunphy","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2015.02.014_bib0985","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/S0140-6736(09)60502-X","article-title":"Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials","volume":"373","author":"Bohlius","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2015.02.014_bib0990","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(03)14567-9","article-title":"Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial","volume":"362","author":"Henke","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2015.02.014_bib0995","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.ijrobp.2007.04.063","article-title":"Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03)","volume":"69","author":"Machtay","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2015.02.014_bib1000","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0360-3016(01)01488-2","article-title":"Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx","volume":"50","author":"Glaser","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2015.02.014_bib1005","first-page":"CD006158","article-title":"Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer","volume":"3","author":"Lambin","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.canrad.2015.02.014_bib1010","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.299.8.914","article-title":"Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia","volume":"299","author":"Bennett","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.canrad.2015.02.014_bib1015","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1593\/neo.04685","article-title":"Erythropoietin signaling promotes invasiveness of human head and neck squamous cell carcinoma","volume":"7","author":"Mohyeldin","year":"2005","journal-title":"Neoplasia"},{"key":"10.1016\/j.canrad.2015.02.014_bib1020","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1002\/stem.156","article-title":"Evaluating erythropoietin-associated tumor progression using archival tissues from a phase III clinical trial","volume":"27","author":"Miller","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.canrad.2015.02.014_bib1025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.2009.25.5638","article-title":"Subcutaneous compared with intravenous administration of amifostine in patients with head and neck cancer receiving radiotherapy: final results of the GORTEC2000-02\u00a0phase III randomized trial","volume":"29","author":"Bardet","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib1030","doi-asserted-by":"crossref","first-page":"e95968","DOI":"10.1371\/journal.pone.0095968","article-title":"Effect of amifostine in head and neck cancer patients treated with radiotherapy: a systematic review and meta-analysis based on randomized controlled trials","volume":"9","author":"Gu","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.canrad.2015.02.014_bib1035","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1200\/JCO.2010.33.1454","article-title":"Effect of amifostine on survival among patients treated with radiotherapy: a meta-analysis of individual patient data","volume":"29","author":"Bourhis","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib1040","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1200\/JCO.2010.32.4095","article-title":"Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study","volume":"29","author":"Le","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib1045","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1200\/JCO.2010.32.4103","article-title":"Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial","volume":"29","author":"Henke","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib1050","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1200\/JCO.2005.05.520","article-title":"Randomized trial of hyperthermia and radiation for superficial tumors","volume":"23","author":"Jones","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2015.02.014_bib1055","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0360-3016(99)00272-2","article-title":"The treatment of high-grade soft tissue sarcomas with preoperative thermoradiotherapy","volume":"45","author":"Prosnitz","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2015.02.014_bib1060","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(00)02059-6","article-title":"Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group","volume":"355","author":"Van der Zee","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2015.02.014_bib1065","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/09553007114550601","article-title":"Variation in sensitivity to heat shock during the cell-cycle of Chinese hamster cells in vitro","volume":"19","author":"Westra","year":"1971","journal-title":"Int J Radiat Biol Relat Stud Phys Chem Med"},{"key":"10.1016\/j.canrad.2015.02.014_bib1070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0006-3495(63)86801-0","article-title":"Variations in several responses of HeLa cells to X-irradiation during the division cycle","volume":"3","author":"Terasima","year":"1963","journal-title":"Biophys J"},{"key":"10.1016\/j.canrad.2015.02.014_bib1075","first-page":"966","article-title":"Response of cells to hyperthermia under acute and chronic hypoxic conditions","volume":"39","author":"Gerweck","year":"1979","journal-title":"Cancer Res"},{"key":"10.1016\/j.canrad.2015.02.014_bib1080","first-page":"2044","article-title":"Heat radiosensitization and the level of DNA polymerases alpha and beta of human colony-forming unit-granulocyte-macrophage and myeloid leukemias sensitive and resistant to chemotherapeutic agents","volume":"50","author":"Mivechi","year":"1990","journal-title":"Cancer Res"},{"key":"10.1016\/j.canrad.2015.02.014_bib1085","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/026567399285828","article-title":"Thermal radiosensitization and repair inhibition in human melanoma cells: a comparison of survival and DNA double strand breaks","volume":"15","author":"Raaphorst","year":"1999","journal-title":"Int J Hyperth"},{"key":"10.1016\/j.canrad.2015.02.014_bib1090","first-page":"5347","article-title":"Radiation therapy and hyperthermia improve the oxygenation of human soft tissue sarcomas","volume":"56","author":"Brizel","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.canrad.2015.02.014_bib1095","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3109\/02656739009140944","article-title":"Head and neck cancers: results of thermoradiotherapy versus radiotherapy","volume":"6","author":"Datta","year":"1990","journal-title":"Int J Hyperth"},{"key":"10.1016\/j.canrad.2015.02.014_bib0550","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0360-3016(94)90154-6","article-title":"Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymph nodes in stage IV head and neck patients","volume":"28","author":"Valdagni","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321815000943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321815000943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:23:48Z","timestamp":1761135828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321815000943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":110,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S1278321815000943"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2015.02.014","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Param\u00e8tres de radior\u00e9sistance des cancers des voies a\u00e9rodigestives sup\u00e9rieures et strat\u00e9gies de radiosensibilisation","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2015.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}